Can a tiny heart pump Fine-Tune support for failing hearts?

NCT ID NCT04451798

Completed Knowledge-focused Sponsor: University of Leipzig Source: ClinicalTrials.gov ↗

First seen Aug 04, 2026 · Last updated Aug 05, 2026 · Updated 1 time

Summary

This study looks at how the Impella CP, a small mechanical heart pump, changes blood flow and heart function in people with cardiogenic shock—a life-threatening condition where the heart can't pump enough blood. Researchers will measure pressures inside the heart and use ultrasound to see how the heart responds at different pump speeds. The goal is to understand the device's acute effects to guide better use in critical care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Impella CP microaxial pump
What this could lead to: If successful, this could help doctors optimize the use of the Impella CP device to better support patients in cardiogenic shock.
What could go wrong: This is a small, observational study, so results may not apply broadly. The device carries risks like bleeding or vascular complications.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIOGENIC SHOCK are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cardiogenic shock Shock, Cardiogenic

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARDIOGENIC SHOCK

Contacts and locations

Locations

University of Jena

Jena, 07747, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.